Camelidae antibodies against imminoglobulin E and use thereof for the treatment of allergic disorders

Details for Australian Patent Application No. 2003283137 (hide)

Owner Ablynx N.V.

Inventors Vaeck, Mark; Van Bergen en Henegouwen, Paul P. M. P.; Silence, Karen

Agent Spruson & Ferguson

Pub. Number AU-B-2003283137

PCT Number PCT/BE2003/0001

PCT Pub. Number WO2004/041867

Priority PCT/EP03/07313 08.07.03 EP; 03447005.4 10.01.03 EP; 60/425,073 08.11.02 US; 60/425,063 08.11.02 US; PCT/EP03/06581 23.06.03 EP

Filing date 7 November 2003

Wipo publication date 7 June 2004

Acceptance publication date 1 July 2010

International Classifications

C07K 16/42 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against immunoglobulins (anti-idiotypic antibodies)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 31/06 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/36 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

G01N 33/577 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

25 March 2004 Complete Application Filed

  Priority application(s): PCT/EP03/07313 08.07.03 EP; 03447005.4 10.01.03 EP; 60/425,073 08.11.02 US; 60/425,063 08.11.02 US; PCT/EP03/06581 23.06.03 EP

1 July 2004 Application Open to Public Inspection

  Published as AU-B-2003283137

1 July 2010 Application Accepted

  Published as AU-B-2003283137

29 July 2010 Corrigenda

  Applications Accepted - Name Index Under the name Ablynx N.V., Application No. 2003283137, under INID (54) correct the title to read Camelidae antibodies against immunoglobulin E and use thereof for the treatment of allergic disorders

28 October 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003283138-THERAPEUTIC POLYPEPTDIDES, HOMOLOGUES THEREOF, FRAGMENTS THEREOF AND FOR USE IN MODULATING PLATELET MEDIATED AGGREGATION

2003283136-CAMELIDAE SINGLE DOMAIN ANTIBODIES VHH DIRECTED AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR AND USES THEREFOR